A Sanofi strategy shift is leading to the end of a gene-editing alliance with Sangamo Therapeutics. Though the partnership has produced encouraging early clinical data with a sickle cell therapy highly personalized to the patient, Sanofi now plans to focus on universal approaches to genomic medicines.
The supply chain needs of the pharmaceutical industry are growing increasingly complex, particularly with the growth of cell and gene therapies that require timely delivery of medication components that have to be kept at stable temperatures.
A new report, Resilience in volatility: Modernizing the supply chain from Microsoft highlights factors that have stressed the supply chain over the past 18 months and how companies are responding to this crisis as they lay the groundwork to minimize the impact of global events in the future.
INVEST 2022 is going to be held March 28-30 in at the Ritz Carlton hotel in Chicago. This year, we have four new categories reflecting the pandemic-reality and how it has reshaped healthcare. Apply now for a chance to pitch LIVE in front of VC judges. Please note that companies that have pitched in the last 12 months at a MedCity event are ineligible to apply. Selected finalists will be asked to register for the conference at a reduced rate. Deadline is January 15.
By Frank Vinluan Thursday, January 6, 2022 6:13 PM
Biotech startup Ambagon Therapeutics is taking a new approach to making elusive protein targets "druggable" by using molecular glues. The biotech has a pipeline of preclinical cancer drugs and it has raised $85 million to support their development.
One reason clinicians struggle to find what they need in EHRs is because most legacy systems were not designed to provide a diagnostically holistic view for specific clinical conditions.
By Frank Vinluan Thursday, January 6, 2022 1:06 PM
A Sanofi strategy shift is leading to the end of a gene-editing alliance with Sangamo Therapeutics. Though the partnership has produced encouraging early clinical data with a sickle cell therapy highly personalized to the patient, Sanofi now plans to focus on universal approaches to genomic medicines.
By Michelle Davey Thursday, January 6, 2022 10:30 AM
This is the time to embrace radical empathy, profound change, and bold ideas. While the pandemic may have put us all on an unexpected path, there is no turning back from here.
By Carlos Abisambra Thursday, January 6, 2022 8:15 AM
We may acknowledge just how essential the nomadic healthcare workforce has been in efforts to control the Covid-19 pandemic, but what's often overlooked is how and where these workers are being housed.
No comments